Please email us at Sales@AmericanPharmaWholesale.com with our item No, NDC#,UPC#or best is product link. We are located in Oceanside, California. Search over 100,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name.
Menu

Rx Item-Tobramycin-Dexamethasone 0.3% 0.1% Sus 10ml By Valeant EXP 7/19

Tobramycin-Dexamethasone 0.3% 0.1% Sus 10Ml By ValeantBRAND: TOBRAMYCIN-DEXAMETHASONE NDC: 24208-0295-10,24208029510 UPC: 3-24208-29510-6,324208295106 Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scopWant to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.comVisit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.Item No.: Rx160503 NDC No.24208029510 UPC No.:324208295106 NDC No. 24208-0295-10 UPC/GTIN No. 3-24208-29510-6 MPN No. 29510 Only Lic.-Physician, Pharmacy, Dentist, Drug Mfg, Dist., Gov, Hospital, Lic.

Rx Item-Tobramycin-Dexamethasone 0.3% 0.1% Sus 10ml By Valeant EXP 7/19

$261.63$171.97

Item No.: Rx160503 NDC No.24208029510 UPC No.:324208295106 NDC No. 24208-0295-10 UPC/GTIN No. 3-24208-29510-6 MPN No. 29510 Only Lic.-Physician, Pharmacy, Dentist, Drug Mfg, Dist., Gov, Hospital, Lic.Lab, Naturalist, Naturopath, NP, Optometrist, Pharmacist, PA, Physical Therapist, Podiatrist, Research Co., Uni., VA, Vet & Wholesalers In Scope Of their Practice Can Order Rx Item. Rx Item No. Rx160503 Tobramycin-Dexamethasone 0.3%/0.1% Suspension 10ml By Valeant/ Item No. 3160503 NDC No. 242080295

Have a question?

INDICATIONS AND USAGE

TOBRADEX® ST ophthalmic suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.



Ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies.

The use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.

The particular anti-infective drug in this product is active against the following common bacterial eye pathogens: Staphylococci , including S. aureus and S. epidermidis (coagulase-positive and coagulase-negative), including penicillin-resistant isolates. Streptococci, including some Group A and other beta-hemolytic species, some nonhemolytic species, and some Streptococcus pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Proteus mirabilis, Morganella morganii, most Proteus vulgaris isolates, Haemophilus influenzae, H. aegyptius, Moraxella lacunata, Acinetobacter calcoaceticus and some Neisseria species.

2 DOSAGE AND ADMINISTRATION

2.1 Recommended Dosing
Instill one drop into the conjunctival sac(s) every four to six hours. During the initial 24 to 48 hours, the dosage may be increased to one drop every two hours. Frequency should be decreased gradually as warranted by improvement in clinical signs. Care should be taken not to discontinue therapy prematurely.

2.2 Prescription Guideline
Not more than 20 mL should be prescribed initially and the prescription should not be refilled without further evaluation as outlined in WARNINGS AND PRECAUTIONS (5).

3 DOSAGE FORMS AND STRENGTHS

TOBRADEX ST ophthalmic suspension contains 3 mg/mL tobramycin and 0.5 mg/mL dexamethasone.

4 CONTRAINDICATIONS

4.1 Nonbacterial Etiology
TOBRADEX ST, as with other ophthalmic corticosteroids, is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. (4.1)

4.2 Hypersensitivity
Hypersensitivity to a component of the medication.

5 WARNINGS AND PRECAUTIONS

5.1 IOP increase
Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision. If this product is used for 10 days or longer, IOP should be monitored.

5.2 Aminoglycoside sensitivity
Sensitivity to topically applied aminoglycosides may occur.

5.3 Cataracts
Use of corticosteroids may result in posterior subcapsular cataract formation.

5.4 Delayed Healing
The use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation. In those diseases causing thinning of the cornea or sclera, perforations have been known to occur with the use of topical steroids. The initial prescription and renewal of the medication order should be made by a physician only after examination of the patient with the aid of magnification such as slit lamp biomicroscopy and, where appropriate, fluorescein staining.

5.5 Bacterial infections
Prolonged use of corticosteroids may suppress the host response and thus increase the hazard of secondary ocular infections. In acute purulent conditions, steroids may mask infection or enhance existing infection. If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated.

5.6 Viral infections
Employment of a corticosteroid medication in the treatment of patients with a history of herpes simplex requires great caution. Use of ocular steroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex).

5.7 Fungal infections
Fungal infections of the cornea are particularly prone to develop coincidentally with long-term local steroid application. Fungus invasion must be considered in any persistent corneal ulceration where a steroid has been used or is in use.

5.8 Use with systemic aminoglycosides
If product is used in combination with systemic aminoglycoside antibiotics the patient should be monitored for total serum concentration.
DESCRIPTION

TOBRADEX® ST (tobramycin / dexamethasone ophthalmic suspension) 0.3%/0.05% is a sterile, isotonic, white, aqueous antibiotic and steroid suspension with a pH of approximately 5.7 and an osmolality of approximately 290 mOsm/kg.

The chemical name of tobramycin is O -3-amino-3-deoxy-?-D-glucopyranosyl-(14)-O -[2,6-diamino-2,3,6-trideoxy-?-D-ribo -hexopyranosyl-(16)]-2-deoxy- L-streptamine. It has a molecular formula of C18 H37 N5 O9 and a molecular weight of 467.52
The chemical name of dexamethasone is 9-fluoro-11?,17,21-trihydroxy-16?-methylpregna-1,4-diene-3,20-dione. It has a molecular formula of C22 H29 FO5 and a molecular weight of 392.47
Each mL of TOBRADEX® ST contains: Actives: tobramycin 3 mg and dexamethasone 0.5 mg. Preservative: benzalkonium chloride 0.1 mg. Inactives: xanthan gum, tyloxapol, edetate disodium, sodium chloride, propylene glycol, sodium sulfate, hydrochloric acid and/or sodium hydroxide (to adjust pH) and purified water.

12 CLINICAL PHARMACOLOGY

12.1 Mechanism of Action
Dexamethasone is a potent corticoid. Corticoids suppress the inflammatory response to a variety of agents and they can delay or slow healing. Since corticoids may inhibit the body's defense mechanism against infection, a concomitant antimicrobial drug may be used when this inhibition is considered to be clinically significant.
Tobramycin is an antibacterial drug. It inhibits the growth of bacteria by inhibiting protein synthesis. Tobramycin is included in this combination product to provide action against susceptible bacteria.
Microbiology
The antibiotic component (tobramycin) in the combination is included to provide action against susceptible bacteria. In vitro studies have demonstrated that tobramycin is active against susceptible isolates of the following bacteria: Staphylococcus aureus (includes penicillin-resistant isolates), Staphylococcus epidermidis (includes penicillin-resistant isolates), Streptococci, including some Group A other beta-hemolytic species, some nonhemolytic species, and some Streptococcus pneumoniae. Acinetobacter calcoaceticus, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Haemophilus aegypticus, Klebsiella pneumoniae, Moraxella lacunata, Morganella morganii, Neisseria perflava, Neisseria sicca, Proteus mirabilis, Proteus vulgaris, Pseudomonas aeruginosa.

In vitro bacterial studies demonstrate that in some cases bacteria resistant to gentamicin are susceptible to tobramycin.
NONCLINICAL TOXICOLOGY

13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
No studies have been conducted to evaluate the carcinogenic or mutagenic potential. No impairment of fertility was noted in studies of subcutaneous tobramycin in rats at doses of 50 and 100 mg/kg/day (equivalent to human doses of 8 and 16 mg/kg/day, at least 2 orders of magnitude greater than the topical ocular dose).

16 HOW SUPPLIED/STORAGE AND HANDLING

TOBRADEX® ST is supplied as a 2.5 mL, 5 mL, or 10 mL suspension in a 4 mL, 8 mL or 10 mL natural polyethylene DROP-TAINER® bottle with a natural polyethylene dispenser tip and a pink polypropylene overcap. Tamper evidence is provided with a shrink band around the closure and neck area of the bottle.

NDC 0065-0652-25: 2.5 mL

NDC 0065-0652-05: 5 mL

NDC 0065-0652-10: 10 mL

Storage

Store at 2° to 25°C (36° to 77°F).

Protect from light.

17 PATIENT COUNSELING INFORMATION

17.1 Storage and Handling
Patients should be instructed to store the bottle upright and away from light. Shake well before using.

17.2 Avoid Contamination
Patients should be instructed not to touch dropper tip to any surface, as this may contaminate the contents.

17.3 Contact Lens Wear
Contact lenses should not be worn during the use of this product.

Alcon Laboratories, Inc.

Fort Worth, Texas 76134 USA

Printed in USA

U.S. Patent No. 7,795,316

©2008, 2011 Alcon, Inc.

Tobramycin-Dexamethasone 0.3% 0.1% Sus 10Ml By Valeant
Tobramycin-Dexamethasone 0.3%
Tobramycin-Dexamethasone 0.3% 0.1% Sus 10Ml By Valeant

BRAND: TOBRAMYCIN-DEXAMETHASONE NDC: 24208-0295-10,24208029510 UPC: 3-24208-29510-6,324208295106
Tobramycin-Dexamethasone 0.3% 0.1% Suspe
BRAND: TOBRAMYCIN-DEXAMETHASONE NDC: 24208-0295-10,24208029510 UPC: 3-24208-29510-6,324208295106

Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop
Click above for Brand!
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop

Want to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.com
Buy More Save More!
Want to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.com

Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.
AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.

Item No.: Rx160503 NDC No.24208029510 UPC No.:324208295106 NDC No. 24208-0295-10 UPC/GTIN No. 3-24208-29510-6 MPN No. 29510 Only Lic.-Physician, Pharmacy, Dentist, Drug Mfg, Dist., Gov, Hospital, Lic.
Rx Item-Tobramycin-Dexamethasone 0.3% 0.
Item No.: Rx160503 NDC No.24208029510 UPC No.:324208295106 NDC No. 24208-0295-10 UPC/GTIN No. 3-24208-29510-6 MPN No. 29510 Only Lic.-Physician, Pharmacy, Dentist, Drug Mfg, Dist., Gov, Hospital, Lic.